Genetic Counseling Follow-Up Note (Hybrid)
A concise follow-up note template for genetic counseling encounters that balances clinical documentation with patient readability. Features a plain-language summary section and problem-oriented structure aligned with NSG…
Document Type
clinical note / Progress Note
Specialties
Template Preview
Date/Time: [date and time of encounter]
Patient: [name, DOB, MRN]
Genetic Counselor: [name, credentials]
Encounter Type: [in-person / telehealth (video) / telehealth (audio-only)]
Reason for Follow-Up: [result disclosure / interval family history update / reanalysis discussion / other reason]
Participants: [patient and any others present; include interpreter language if applicable]
Referring Clinician: [name, specialty]
Summary
(Write 3–5 brief bullets in plain language accessible to patients. Define genetic terms parenthetically. This summary should stand alone for quick reference.)
- [Reason for today's visit in plain language]
- [What changed since the initial consult that affects risk or testing strategy]
- [Key results discussed and what they mean]
- [Main decision(s) made today]
- [Most important next step(s) and timing]
Interval History and Pedigree Update
[Interval medical events, new diagnoses or symptoms, relevant reproductive history changes, and any new external records reviewed since the initial consult]
Patient's goals for this visit: [stated goals and questions]
Pedigree review: [state that pedigree was reviewed; summarize updates including new diagnoses in relatives, updated ages, deaths, new genetic test results in family members, and source of information] (Include ancestry or consanguinity updates only if clinically relevant. Note missing information and plan to obtain it.)
Prior testing context: [brief reference to prior patient or family testing and known limitations that inform current recommendations] (Include only if relevant to current strategy.)
Results Reviewed
(Include this section only if new results were discussed. For each test, identify the laboratory, test name, and report date.)
Test: [laboratory, test name, report date]
Result: [result category: pathogenic / likely pathogenic / VUS / likely benign / benign] in [gene(s)] (Use "variant," not "mutation." Include HGVS nomenclature and zygosity if applicable.)
Clinical interpretation: [interpretation tied to patient's phenotype and indication; use calibrated language such as "consistent with," "increases the likelihood of," or "does not rule out"; include uncertainty, limitations, and residual risk]
(Repeat the above block for each additional test as needed.)
Counseling and Assessment
Patient questions and decisional considerations: [patient-stated questions, goals, and any decisional conflict] (Use neutral language.)
Targeted education provided: [conditions discussed, inheritance pattern, penetrance and expressivity as relevant, and how risk was communicated]
Testing decisions and consent: [testing ordered / offered and declined] (If ordered, document: purpose and scope, possible result types, approach to secondary findings if applicable, limitations, recontact and reclassification expectations, and privacy considerations. If declined, state patient's reasoning in neutral terms.)
Psychosocial considerations: [brief observations that affected understanding or decision-making] (Include only if relevant.)
Assessment: [problem-oriented assessment for each indication addressed, stating the clinical question, key supporting evidence, assessment with calibrated certainty, and rationale for chosen next steps] (Clearly label any clinical inference. Add separate paragraphs for each indication if multiple are addressed.)
Plan
(Provide actionable recommendations with responsible party and timing.)
- Testing: [tests recommended or ordered with rationale and logistics; contingency plan if results are negative or inconclusive]
- Medical management: [screening, surveillance, and referrals categorized as recommended now, consider, or defer pending results; include responsible clinician and timing]
- Family implications: [relatives who should consider cascade testing; recommended approach; whether family letter was provided or discussed]
- Reproductive counseling: [partner testing, carrier screening, PGT, or prenatal diagnosis options with timing and referrals] (Include only if relevant.)
- Resources provided: [written materials, websites, or support organizations]
- Follow-up: [how and when results will be returned; next appointment or reanalysis interval; triggers for earlier contact]
Total time spent: [minutes] (Include only if billing by time.)
Signature: [Genetic Counselor name, credentials]
Cosignature: [Supervising clinician name, credentials] (Include only if applicable.)
Want to use this template?
Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.